Senior Lecturer
Cannabis
Tom Freeman is the Director of the Addiction and Mental Health Group (AIM), an interdisciplinary research group bridging the departments of Psychology and Pharmacy & Pharmacology at the University of Bath. He is an elected Trustee and Director of the Society for the Study of Addiction, and Senior Editor for the journal Addiction. He conducts commissioned projects for the European Union drugs agency and has given expert evidence for the National Institute of Health and Care Excellence (NICE) and the Advisory Council on the Misuse of Drugs (ACMD).
Tom is internationally known for his research on cannabis and cannabinoids. His work includes: observational studies characterising changes in cannabis products and their association with addiction and mental health outcomes; novel harm reduction strategies such as standard THC units (similar to standard alcohol units) and understanding how cannabidiol influences the effects of cannabis; clinical trials of treatments for cannabis use disorder.